A rare pulmonary complication of myeloma

[1]  K. Jeon,et al.  Thalidomide Induced Nonspecific Interstitial Pneumonia in Patient with Relapsed Multiple Myeloma , 2010, The Korean journal of internal medicine.

[2]  S. Cho,et al.  Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient , 2010, Yonsei medical journal.

[3]  H. Matsushima,et al.  [Case of thalidomide-induced interstitial pneumonia]. , 2009, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[4]  K. Sugimoto,et al.  Thalidomide may induce interstitial pneumonia preferentially in Japanese patients , 2009, European journal of haematology.

[5]  C. Roberts,et al.  Acute Pulmonary Toxicity from Thalidomide in a Patient with Multiple Myeloma , 2007, Radiology case reports.

[6]  J. Chan,et al.  Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. , 2006, Gynecologic oncology.

[7]  M. Dimopoulos,et al.  Pulmonary toxicity from novel antineoplastic agents. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  S. Tyring,et al.  Thalidomide: dermatological indications, mechanisms of action and side‐effects , 2005, The British journal of dermatology.

[9]  M. Asaka,et al.  Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Foucher,et al.  Drug-induced and iatrogenic infiltrative lung disease. , 2004, Clinics in chest medicine.

[11]  W. Mccune,et al.  Update on immunosuppressive therapy. , 1998, Current opinion in rheumatology.

[12]  J. Potjewijd,et al.  [Interstitial pneumonitis as an adverse effect of thalidomide]. , 2009, Nederlands tijdschrift voor geneeskunde.